Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Tomsicek Michael John received 9,366 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Tomsicek Michael John (Director) received 9,366 Acrivon Therapeutics, Inc. shares as an award, leaving 9,366 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 9,366 shares
- Holding after
- 9,366 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 9,366 | 9,366 | Direct |